Sprinzl et al.4141 Sprinzl MF, Weinmann A, Lohse N, Tönissen H, Koch S, Schattenberg J, et al. Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. Transpl Int. 2013; 26(1):67-74.
|
44 |
24 |
48 |
|
|
|
52 |
Seo et al.4040 Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, et al. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl. 2007; 13(6):844-7.
|
68 |
28 |
|
38 |
|
25 |
69 |
El Atrache et al.1919 El Atrache MM, Abouljoud MS, Divine G, Yoshida A, Kim DY, Kazimi MM, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transpl. 2012; 26(5):E505-12.
|
83 |
45 |
53 |
76 |
|
|
71 |
Hanouneh et al.4444 Hanouneh IA, Macaron C, Lopez R, Feldstein AE, Yerian L, Eghtesad B, et al. Recurrence of disease following liver transplantation: nonalcoholic steatohepatitis vs hepatitis C virus infection. Int J Organ Transplant Med. 2011; 2(2):57-65.
|
148 |
60 |
53 |
59 |
|
|
60 |
Bianchi et al.4545 Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl. 2008; 14(11):1648-54.
|
296 |
38 |
45 |
38 |
29.4 |
50 |
52.7 |
Laryea et al.4646 Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl. 2007; 13(8):1109-14.
|
118 |
>60 |
58 |
|
|
48 |
62 |
Laish et al.3535 Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011; 17(1):15-22.
|
252 |
>60 |
52 |
|
|
|
|
Anastácio et al.4747 Anastácio LR, Ferreira LG, Ribeiro HS, Liboredo JC, Lima AS, Correia MI. Metabolic syndrome after liver transplantation: prevalence and predictive factors. Nutrition. 2011; 27(9):931-7.
|
148 |
>60 |
50 |
|
|
|
60 |
Yalamanchili et al.2424 Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl. 2010; 16(4):431-9.
|
257 |
60 |
|
36.8 |
|
|
52 |
Lv et al.4848 Lv C, Zhang Y, Chen X, Huang X, Xue M, Sun Q, et al. New-onset diabetes after liver transplantation and its impact on complications and patient survival. J Diabetes. 2015;7(6):881-90.
|
438 |
60 |
|
18 |
|
|
|
Dumortier et al.1212 Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Am J Gastroenterol. 2010; 105(3):613-20.
|
421 |
>6 |
|
23.5 |
|
12 |
51.8 |
Marroni et al.1616 Marroni CA, Hoppe L, Diehl JL, Leipnitz I, Brandão AB, Cassal AP, et al. Diabetes mellitus and liver transplantation in adults. Transplant Proc. 1999; 31(7):3046.
|
75 |
>3 |
|
38 |
|
|
|
Kennedy et al.2222 Kennedy C, Redden D, Gray S, Eckhoff D, Massoud O, McGuire B, et al. Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford). 2012; 14(9):625-34.
|
129 |
>60 |
|
59 |
|
|
|
Ong et al.1010 Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl. 2001; 7(9):797-801.
|
13 |
>60 |
|
53 |
|
|
|
Agopian et al.2121 Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012; 256(4):624-33.
|
144 |
60 |
|
57 |
|
|
50 |
Vallin et al.88 Vallin M, Guillaud O, Boillot O, Hervieu V, Scoazec JY, Dumortier J. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Liver Transpl. 2014; 20(9):1064-71.
|
80 |
>60 |
|
37.8 |
|
|
52 |
Parolin et al.1717 Parolin MB, Zaina FE, Araújo MV, Kupka E, Coelho JC. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: association with HCV infection. Transplant Proc. 2004; 36(9):2776-7.
|
82 |
20 |
|
|
18.9 |
|
|
Mirabella et al.4949 Mirabella S, Brunati A, Ricchiuti A, Pierini A, Franchello A, Salizzoni M. New-onset diabetes after liver transplantation. Transplant Proc. 2005; 37(6):2636-7.
|
830 |
10 |
|
|
10.8 |
|
|
Ling et al.5050 Ling Q, Xu X, Xie H, Wang K, Xiang P, Zhuang R, et al. New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry. Liver Int. 2016; 36(5):705-12.
|
10,204 |
30 |
|
|
24.3 |
|
|
Carey et al.5151 Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, et al. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant. 2012:614781.
|
225 |
>12 |
|
|
17.3 |
|
|
Saliba et al.5252 Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007; 13(1):136-44.
|
211 |
24 |
|
|
22.7 |
|
|
Moon et al.5353 Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation. 2006; 82(12):1625-8.
|
778 |
57 |
|
|
36.5 |
|
|
Gisbert et al.5454 Gisbert C, Prieto M, Berenguer M, Bretó M, Carrasco D, Juan M, et al. Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg. 1997; 3(4):416-22.
|
85 |
>12 |
|
|
|
66 |
|
Trotter et al.5555 Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, et al. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Liver Transpl. 2001; 7(5):401-8.
|
57 |
>6 |
|
|
|
30 |
|
Dehghani et al.
5656 Dehghani SM, Taghavi SA, Eshraghian A, Gholami S, Imanieh MH, Bordbar MR, et al. Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors. J Gastroenterol. 2007; 42(9):769-74.
|
170 |
>12 |
|
|
|
70 |
|
Marroni et al.1515 Marroni CA, Diehl JL, Leipnitz I, Pires LM, Brandão AB, Cassal AP, et al. Prevalence of high blood pressure in patients submitted to liver transplantation at the ISCMPA. Transplantation Proc. 1999; 31(7):3047.
|
75 |
> 3 |
|
|
|
|
14
|
Darstein et al.5757 Darstein F, König C, Hoppe-Lotichius M, Grimm D, Knapstein J, Zimmermann A, et al. New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor. Eur J Intern Med. 2015; 26(6):439-44.
|
255 |
>60 |
|
|
|
|
55 |
Hejlova et al.3232 Hejlova I, Honsova E, Sticova E, Lanska V, Hucl T, Spicak J, et al. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes. Liver Transpl. 2016; 22(5):644-55.
|
309 |
>120 |
|
|
|
|
67 |
Canzanello et al.5858 Canzanello VJ, Textor SC, Taler SJ, Schwartz LL, Porayko MK, Wiesner RH, et al. Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). Liver Transpl Surg. 1998; 4(4):328-34.
|
158 |
>24 |
|
|
|
|
82 |